propafenone has been researched along with cysteine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Amorós, I; Barana, A; Caballero, R; De Palm, SH; Delpón, E; Gómez, R; Iriepa, I; Matamoros, M; Núñez, M; Pérez-Hernández, M; Tamargo, J | 1 |
1 review(s) available for propafenone and cysteine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for propafenone and cysteine
| Article | Year |
|---|---|
Structural basis of drugs that increase cardiac inward rectifier Kir2.1 currents.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Binding Sites; CHO Cells; Cricetulus; Cysteine; Dose-Response Relationship, Drug; Guinea Pigs; Heart Rate; Humans; Ion Channel Gating; Membrane Potentials; Membrane Transport Modulators; Molecular Docking Simulation; Molecular Structure; Myocytes, Cardiac; Potassium Channels, Inwardly Rectifying; Propafenone; Protein Binding; Signal Transduction; Structure-Activity Relationship; Time Factors; Transfection | 2014 |